Palvella Therapeutics director Christopher P. Kiritsy disposes of 313 common shares for $49,141
PVLA•Director share sale and option exercise
- Director Christopher P. Kiritsy cut his Palvella Therapeutics stake to 250 shares on Sep. 2, 2026.
- Sold 313 common shares at USD 157 per share.
- Exercised stock options for 313 shares at USD 127.2 per share.
